Financial Network Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$180K Buy
6,393
+107
+2% +$2.85K 0.18% 100
2025
Q4
$157K Hold
6,286
0.16% 114
2025
Q3
$160K Buy
6,286
+45
+0.7% +$1.11K 0.18% 112
2025
Q2
$151K Hold
6,241
0.18% 114
2025
Q1
$158K Buy
6,241
+1,363
+28% +$35.7K 0.21% 92
2024
Q4
$129K Sell
4,878
-2,151
-31% -$58.3K 0.24% 84
2024
Q3
$203K Sell
7,029
-1,466
-17% -$42.8K 0.17% 111
2024
Q2
$238K Buy
8,495
+172
+2% +$4.74K 0.18% 114
2024
Q1
$231K Buy
8,323
+276
+3% +$7.66K 0.23% 105
2023
Q4
$232K Buy
+8,047
New +$243K 0.25% 100

Other funds holding PFE

Financial Network Wealth Advisors's PFE Position: Q1 2026 in Review

Financial Network Wealth Advisors increased its Pfizer (PFE) stake by 1.7% in Q1 2026, buying an estimated $2.85K and bringing the position to 6,393 shares worth $180K. The position accounts for 0.18% of the portfolio, ranked #100.

Financial Network Wealth Advisors first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $238K in Q2 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Financial Network Wealth Advisors held 6,393 shares of Pfizer worth $180K as of Q1 2026.
  • Financial Network Wealth Advisors bought 107 Pfizer shares in Q1 2026, an estimated $2.85K.
  • Pfizer made up 0.18% of Financial Network Wealth Advisors's portfolio in Q1 2026, its #100 holding.
  • Financial Network Wealth Advisors first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Financial Network Wealth Advisors's Pfizer position peaked at $238K in Q2 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.